This statistic shows the percentage of return on investments in research and development among mid cap biopharmaceutical companies from 2013 to 2020. Within this time period, the returns declined from 17.4 percent to 5.2 percent in 2019. In 2020. returns increased slightly to 6.6 percent.
Advertisement
Advertisement
Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Deloitte. (May 24, 2021). Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020 [Graph]. In Statista. Retrieved June 28, 2025, from https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/
Deloitte. "Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020." Chart. May 24, 2021. Statista. Accessed June 28, 2025. https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/
Deloitte. (2021). Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020. Statista. Statista Inc.. Accessed: June 28, 2025. https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/
Deloitte. "Percentage Return on Investments in Research and Development among mid Cap Biopharma Companies from 2013 to 2020." Statista, Statista Inc., 24 May 2021, https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/
Deloitte, Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020 Statista, https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/ (last visited June 28, 2025)
Percentage return on investments in research and development among mid cap biopharma companies from 2013 to 2020 [Graph], Deloitte, May 24, 2021. [Online]. Available: https://www.statista.com/statistics/825714/randd-returns-among-mid-cap-biopharma-companies/
